Jelesoff NE et al. (2006) Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemia. Endocr Pract 12: 159–164 In clinical practice ...

ANN ARBOR, Mich., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a licensing agreement with Neopharm Israel for the exclusive rights to ...

IMPORTANT SAFETY INFORMATIONNEXLIZET and NEXLETOL are contraindicated in patients with a prior hypersensitivity to bempedoic acid or ezetimibe or any of the excipients. Serious hypersensitivity ...

INDICATION NEXLIZET and NEXLETOL are indicated: NEXLIZET and NEXLETOL are contraindicated in patients with a prior hypersensitivity to bempedoic acid or ezetimibe or any of the excipients.

The phase 3 TANDEM clinical trial (NCT06005597) was designed to evaluate 10 mg Obicetrapib and 10 mg Ezetimibe fixed-dose combination in adult patients with HeFH and/or ASCVD or multiple ASCVD risk ...

A research team led by Hong Soon-joon, Cha Jung-joon, and Kim Joo-hyun of the Department of Circulatory Mechanics at Korea ...

THERE ARE MANY misconceptions about important cardiovascular metrics. Often people think their risk of heart disease and ...

Although these cholesterol medications are some of the safest and most effective, they can come with unwanted side effects. We asked a doctor to explain.

The combination of orlistat with statins, fenofibrate and ezetimibe led to greater reductions of LDL-C levels compared with each monotherapy. The combination of orlistat with fenofibrate or ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

NPPA fixes retail prices for 65 new drug formulations and ceiling prices for 13, including vaccines and essential drugs.

Healthcare innovators are gaining momentum as they address critical challenges in biotechnology, medical devices, and ...